Animal model studies suggest that change in the members of the suppressor of the cytokine signaling (SOCS) family (mainly SOCS1 and SOCS3) is linked to the pathogenesis of obesity-related metabolic disorders. This evidence concerns the gene SOCS3 and obesity due to melanocortin 4 receptor deficiency.